Confirmed Control Closed Deal verified ConsumerIngredientsProbioticsProbiotics Ingredients
Ganeden acquired by Kerry Group
Kerry Group acquired Ganeden, a probiotics ingredients brand on Oct 11, 2017. Financial terms were not publicly disclosed. The current comp implies EV / revenue of 6x. Public sources confirm the deal; valuation inputs may include estimates where transaction materials do not disclose the full economics.
Transaction summary
- Target
- Ganeden
- Acquirer
- Kerry Group
- Seller
- -
- Announced
- 2017-10-11
- Geography
- -
- Tags
- ConsumerIngredientsProbioticsProbiotics Ingredients
- Type
- Acquisition
- Deal type
- Control
- Stake acquired
- -
- First added
- 2026-06-19
- Latest update
- 2026-06-19
Value and multiples
Price / value
Undisclosed
-
Basis: FundComb estimate
EV / revenue
6x
unknown
Basis: FundComb estimate
EV / EBITDA
20x
Basis: FundComb estimate
Basis
- Financial terms were not disclosed in the public sources reviewed.
- EV / revenue is shown as 6x based on the available comp inputs.
- Revenue and multiple inputs are not fully disclosed in public transaction materials reviewed; treat the multiple as an estimate.
- EV / EBITDA is shown as 20x based on the available comp inputs.
Source summary
No public source summary has been published for this transaction yet.